Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.
about
Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugsNCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytesNitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosisPotential cardioprotective actions of no-releasing aspirinNCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail arteryNon-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cyclePharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersTherapeutic effects of nitric oxide-aspirin hybrid drugsMechanism of action of novel NO-releasing furoxan derivatives of aspirin in human plateletsNO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice.Neointimal formation is reduced after arterial injury in human crp transgenic miceNitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccinationBeneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress.Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic miceBeneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress.Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirinRecent developments in nitric oxide donor drugs.Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury.Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury.Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP.
P2860
Q24672983-35D5A9CF-E728-442A-BC3E-AA8BBAA2D188Q28190347-A78476A8-F264-4C6B-B180-B07EB176226EQ28193414-C224DBDB-0939-4C6A-A67B-0E2D2397575DQ28193422-6B6EC356-00F7-4408-9450-4DFDD45D6151Q28193679-4E478054-C85C-4646-8ED9-10A1AF3DAE5CQ28196440-13EE2EC8-DCA5-499D-9504-2AFF560DD393Q28200449-EBA894AD-62CF-4535-B8F7-60A44DE7E620Q28210282-7EFF17BC-A07C-47B5-93B2-AFA616856B8BQ28218042-A5809EF5-3B4C-48E4-874A-759CD1B1951AQ33705167-DDAA1351-0363-44FC-93BF-E130EFE1D898Q33802547-A41AF0DA-9050-463D-8734-0E68A1B63895Q33932627-A59300B7-CC15-47CE-93E8-BA0535A618CBQ33935253-04D401EB-8A5F-487E-907B-C3558AB13C15Q34010668-352067C3-9732-422A-957E-724B3DE1125FQ34156437-0761FD8D-8A9B-47E6-A28E-3EA643A54F3AQ34331467-7D0D9E64-28D7-49D5-9A5F-4BFC2415E0F8Q34574584-344EF5C7-5D3C-45F9-8160-EEC8D0C6873FQ36052815-E14108A4-4BCB-4A78-875A-319634463B85Q36625450-8A494E76-29A3-48B1-BE92-FBFAA38A1214Q36661502-6CD17353-9639-44C9-A9FE-2B399A265B1FQ37420916-C03A7ED3-258D-4F7D-95B4-EB440F5E78B3Q38558587-554D195D-D463-466A-96AE-2EA1D9C5D5D1Q39626523-5092CFB3-0418-46DA-BED2-4EFE13C0375CQ43826766-3350CFE1-31EC-4132-ADDB-B2D52613F031
P2860
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@ast
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@en
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@nl
type
label
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@ast
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@en
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@nl
prefLabel
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@ast
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@en
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@nl
P2093
P2860
P50
P356
P1476
Effects of nitric oxide-releas ...... in hypercholesterolemic mice.
@en
P2093
M Condorelli
P Del Soldato
R Sorrentino
P2860
P304
P356
10.1073/PNAS.041602898
P407
P577
2001-02-01T00:00:00Z